Editorial comment. Which patients with undetectable PSA levels 5 years after radical prostatectomy are still at risk of recurrence?--Implications for a risk-adapted follow-up strategy.
Publication
, Other
Moul, JW
Published in: Urology
November 2010
Duke Scholars
Published In
Urology
DOI
EISSN
1527-9995
Publication Date
November 2010
Volume
76
Issue
5
Start / End Page
1205
Location
United States
Related Subject Headings
- Workforce
- Urology & Nephrology
- Urology
- Risk
- Prostatic Neoplasms
- Prostatectomy
- Prostate-Specific Antigen
- Neoplasm Recurrence, Local
- Neoplasm Metastasis
- Male
Citation
APA
Chicago
ICMJE
MLA
NLM
Moul, J. W. (2010). Editorial comment. Which patients with undetectable PSA levels 5 years after radical prostatectomy are still at risk of recurrence?--Implications for a risk-adapted follow-up strategy. Urology. United States. https://doi.org/10.1016/j.urology.2010.04.055
Moul, Judd W. “Editorial comment. Which patients with undetectable PSA levels 5 years after radical prostatectomy are still at risk of recurrence?--Implications for a risk-adapted follow-up strategy.” Urology, November 2010. https://doi.org/10.1016/j.urology.2010.04.055.
Moul, Judd W. “Editorial comment. Which patients with undetectable PSA levels 5 years after radical prostatectomy are still at risk of recurrence?--Implications for a risk-adapted follow-up strategy.” Urology, vol. 76, no. 5, Nov. 2010, p. 1205. Pubmed, doi:10.1016/j.urology.2010.04.055.
Published In
Urology
DOI
EISSN
1527-9995
Publication Date
November 2010
Volume
76
Issue
5
Start / End Page
1205
Location
United States
Related Subject Headings
- Workforce
- Urology & Nephrology
- Urology
- Risk
- Prostatic Neoplasms
- Prostatectomy
- Prostate-Specific Antigen
- Neoplasm Recurrence, Local
- Neoplasm Metastasis
- Male